申请人:Epizyme, Inc.
                            
                            
                                公开号:US20190300502A1
                            
                            
                                公开(公告)日:2019-10-03
                            
                            The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.